(Q37728774)

English

Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus

scientific article published on 17 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1 reference

Europe PubMed Central

Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

Edzard Schwedhelm

2

object named as

Edzard Schwedhelm

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Ramachandran S. Vasan

object named as

Ramachandran S Vasan

4

0 references

author name string

Maike Anderssohn

1

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Nicole Lüneburg

3

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Rainer H Böger

5

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

language of work or name

0 references

publication date

17 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Diabetes and Vascular Disease Research

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

105-118

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

The Role of Endothelium in the Responses of Vascular Smooth Muscle to Drugs

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Reduced basal NO-mediated dilation and decreased endothelial NO-synthase expression in coronary vessels of spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

The clinical pharmacology of L-arginine

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Purification and characterization of the constitutive nitric oxide synthase from human placenta

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Microvascular function relates to insulin sensitivity and blood pressure in normal subjects

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Intravenous intralipid-induced blood pressure elevation and endothelial dysfunction in obese African-Americans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Insulin causes endothelial dysfunction in humans: sites and mechanisms.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Additional contribution of emerging risk factors to the prediction of the risk of type 2 diabetes: evidence from the Western New York Study

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Modulation of regional nitric oxide metabolism: blood glucose control or insulin?

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Arginine metabolism: nitric oxide and beyond

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Disruption of methylarginine metabolism impairs vascular homeostasis

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Extensive characterization of the human DDAH1 transgenic mice

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in de

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Vascular reactivity

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Circulating concentrations of asymmetrical dimethyl-L-arginine are increased in women with previous gestational diabetes.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Circulating asymmetric dimethylarginine, endothelin-1 and cell adhesion molecules in women with gestational diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxid

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Nitrosative stress and pathogenesis of insulin resistance

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Endothelial dysfunction: the first step toward coronary arteriosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Identifiers

10.1177/1479164110366053

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37728774&oldid=2171855728"